Bio-Rad Laboratories Inc (BIO)
333.59
+8.01
(+2.46%)
USD |
NYSE |
Nov 22, 14:40
Bio-Rad Laboratories Total Assets (Quarterly): 10.60B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.60B |
| June 30, 2024 | 9.688B |
| March 31, 2024 | 12.61B |
| December 31, 2023 | 12.30B |
| September 30, 2023 | 11.90B |
| June 30, 2023 | 11.98B |
| March 31, 2023 | 13.67B |
| December 31, 2022 | 13.50B |
| September 30, 2022 | 12.06B |
| June 30, 2022 | 12.68B |
| March 31, 2022 | 14.37B |
| December 31, 2021 | 17.80B |
| September 30, 2021 | 19.95B |
| June 30, 2021 | 15.12B |
| March 31, 2021 | 13.93B |
| December 31, 2020 | 12.97B |
| September 30, 2020 | 12.02B |
| June 30, 2020 | 10.10B |
| March 31, 2020 | 8.684B |
| December 31, 2019 | 8.009B |
| September 30, 2019 | 7.177B |
| June 30, 2019 | 7.647B |
| March 31, 2019 | 6.863B |
| December 31, 2018 | 5.611B |
| September 30, 2018 | 6.719B |
| Date | Value |
|---|---|
| June 30, 2018 | 6.386B |
| March 31, 2018 | 6.215B |
| December 31, 2017 | 4.273B |
| September 30, 2017 | 4.186B |
| June 30, 2017 | 4.143B |
| March 31, 2017 | 3.953B |
| December 31, 2016 | 3.851B |
| September 30, 2016 | 4.020B |
| June 30, 2016 | 3.875B |
| March 31, 2016 | 3.753B |
| December 31, 2015 | 3.710B |
| September 30, 2015 | 3.666B |
| June 30, 2015 | 3.525B |
| March 31, 2015 | 3.326B |
| December 31, 2014 | 3.341B |
| September 30, 2014 | 3.386B |
| June 30, 2014 | 3.468B |
| March 31, 2014 | 3.441B |
| December 31, 2013 | 3.389B |
| September 30, 2013 | 3.280B |
| June 30, 2013 | 3.483B |
| March 31, 2013 | 3.457B |
| December 31, 2012 | 3.444B |
| September 30, 2012 | 3.303B |
| June 30, 2012 | 3.169B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
8.009B
Minimum
Dec 2019
19.95B
Maximum
Sep 2021
12.70B
Average
12.45B
Median
Total Assets (Quarterly) Benchmarks
| Agilent Technologies Inc | 11.00B |
| Bruker Corp | 6.113B |
| Azenta Inc | 2.100B |
| Harvard Bioscience Inc | 131.24M |
| Bionano Genomics Inc | 87.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.116B |
| Shareholders Equity (Quarterly) | 7.488B |
| Debt to Equity Ratio | 0.1604 |
| Current Ratio | 6.136 |
| Net Debt Paydown Yield | -0.01% |